Senseonics gets Medicare payment rate decision, has Q3 loss

Health care providers will be able to bill Medicare directly for inserting a Germantown company's implantable blood sugar monitor into patients under new federal policies for 2020.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *